OpenBilldrug price receipt

NADAC week of 2026-10-14

DILTIAZEM 30 MG TABLET

For 30 tablets

Pharmacies pay

$1.49 filed

30 × $0.04955 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$6.51 filed

30 × $0.21692 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.4× estimated

Medicare paid 4.4× what pharmacies pay.

Part D averages every strength and form sold under “Diltiazem HCl*” / “Diltiazem HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.71 estimated

$1.49 + $0.22 (15%) + $5.00 fee per fill = $6.71

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DILTIAZEM 30 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as diltiazem hydrochloride.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., ScieGen Pharmaceuticals, Inc and American Health Packaging.

FDA’s Established Pharmacologic Class for it is Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes); the FDA directory lists 7 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.49 for 30 tablets (30 × $0.04955 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 5 labelers

LabelerNDCsPharmacies pay per unit
ScieGen Pharmaceuticals, Inc2$0.04955 per EA filed
Teva Pharmaceuticals USA, Inc.2$0.04955 per EA filed
Alembic Pharmaceuticals Inc.1$0.04955 per EA filed
American Health Packaging1$0.04955 per EA filed
Chartwell RX, LLC1$0.04955 per EA filed
Not listed as a package in the FDA directory3$0.04955 per EA filed
All 10 NDCs, with labeler and price
  • 00093-0318-01 · Teva Pharmaceuticals USA, Inc. · $0.04955 per EA · eff. 2026-09-23 filed
  • 00093-0318-05 · Teva Pharmaceuticals USA, Inc. · $0.04955 per EA · eff. 2026-09-23 filed
  • 42799-0129-01 · not listed as a package in the FDA directory · $0.04955 per EA · eff. 2026-09-23 filed
  • 42799-0129-02 · not listed as a package in the FDA directory · $0.04955 per EA · eff. 2026-09-23 filed
  • 50228-0481-01 · ScieGen Pharmaceuticals, Inc · $0.04955 per EA · eff. 2026-09-23 filed
  • 50228-0481-05 · ScieGen Pharmaceuticals, Inc · $0.04955 per EA · eff. 2026-09-23 filed
  • 60687-0717-01 · American Health Packaging · $0.04955 per EA · eff. 2026-09-23 filed
  • 60687-0717-11 · not listed as a package in the FDA directory · $0.04955 per EA · eff. 2026-09-23 filed
  • 62135-0333-12 · Chartwell RX, LLC · $0.04955 per EA · eff. 2026-09-23 filed
  • 62332-0781-31 · Alembic Pharmaceuticals Inc. · $0.04955 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

38 other products in the NADAC file share the FDA nonproprietary name diltiazem hydrochloride with DILTIAZEM 30 MG TABLET. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.

ProductPharmacies pay per unitMedicare per unit
CARTIA XT 120 MG CAPSULE
generic · capsule, extended release
$0.14353 per EA filed
eff. 2026-09-23
$0.36508 per EA filed
Part D 2024 average
CARTIA XT 180 MG CAPSULE
generic · capsule, extended release
$0.1873 per EA filed
eff. 2026-09-23
$0.36508 per EA filed
Part D 2024 average
CARTIA XT 240 MG CAPSULE
generic · capsule, extended release
$0.19688 per EA filed
eff. 2026-09-23
$0.36508 per EA filed
Part D 2024 average
CARTIA XT 300 MG CAPSULE
generic · capsule, extended release
$0.30196 per EA filed
eff. 2026-09-23
$0.36508 per EA filed
Part D 2024 average
DILT XR 120 MG CAPSULE
generic · capsule, extended release
$0.31058 per EA filed
eff. 2026-09-23
We don’t know yet
DILT XR 180 MG CAPSULE
generic · capsule, extended release
$0.36629 per EA filed
eff. 2026-09-23
We don’t know yet
DILT XR 240 MG CAPSULE
generic · capsule, extended release
$0.48864 per EA filed
eff. 2026-09-23
We don’t know yet
DILTIAZEM 12HR ER 60 MG CAP
generic · capsule, extended release
$1.42657 per EA filed
eff. 2026-09-23
$1.7737 per EA filed
Part D 2024 average
DILTIAZEM 12HR ER 90 MG CAP
generic · capsule, extended release
$1.66135 per EA filed
eff. 2026-09-23
$1.7737 per EA filed
Part D 2024 average
DILTIAZEM 12HR ER 120 MG CAP
generic · capsule, extended release
$1.97043 per EA filed
eff. 2026-09-23
$1.7737 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(CD) 120 MG CP
generic · capsule, extended release / capsule, coated, extended release
$0.14353 per EA filed
eff. 2026-09-23
$0.38833 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(CD) 180 MG CP
generic · capsule, extended release / capsule, coated, extended release
$0.1873 per EA filed
eff. 2026-09-23
$0.38833 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(CD) 240 MG CP
generic · capsule, extended release / capsule, coated, extended release
$0.19688 per EA filed
eff. 2026-09-23
$0.38833 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(CD) 300 MG CP
generic · capsule, extended release / capsule, coated, extended release
$0.30196 per EA filed
eff. 2026-09-23
$0.38833 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(CD) 360 MG CP
generic · capsule, extended release
$0.33265 per EA filed
eff. 2026-09-23
$0.38833 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(LA) 120 MG TB
generic · tablet, extended release
$1.12264 per EA filed
eff. 2026-09-23
$1.50646 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(LA) 180 MG TB
generic · tablet, extended release
$1.03058 per EA filed
eff. 2026-09-23
$1.50646 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(LA) 240 MG TB
generic · tablet, extended release
$1.0087 per EA filed
eff. 2026-09-23
$1.50646 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(LA) 300 MG TB
generic · tablet, extended release
$1.92826 per EA filed
eff. 2026-09-23
$1.50646 per EA filed
Part D 2024 average
DILTIAZEM 24H ER(LA) 360 MG TB
generic · tablet, extended release
$1.83372 per EA filed
eff. 2026-09-23
$1.50646 per EA filed
Part D 2024 average
DILTIAZEM 30 MG TABLET this page
generic · tablet, film coated / tablet
$0.04955 per EA filed
eff. 2026-09-23
$0.21692 per EA filed
Part D 2024 average
DILTIAZEM 60 MG TABLET
generic · tablet, film coated / tablet
$0.07145 per EA filed
eff. 2026-09-23
$0.21692 per EA filed
Part D 2024 average
DILTIAZEM 90 MG TABLET
generic · tablet, film coated / tablet
$0.0699 per EA filed
eff. 2026-09-23
$0.21692 per EA filed
Part D 2024 average
DILTIAZEM 120 MG TABLET
generic · tablet, film coated / tablet
$0.09903 per EA filed
eff. 2026-09-23
$0.21692 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 10 NDCs’ NADAC prices is $0.04955 per EA filed.

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 104 have a higher middle NADAC price and 3 a lower one. The one in the middle is DILTIAZEM 24H ER(LA) 240 MG TB, at $1.0087 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $6.51 for 30 tablets, at an average of $0.21692 per EA in 2024 (2024-01-01 to 2024-12-31) for “Diltiazem HCl*” and “Diltiazem HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 707,541 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

8 of the product’s 10 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for DILTIAZEM 30 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Diltiazem HCl* / Diltiazem HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (25 of the 31 the name join matched); NDCs of another route or with no known FDA route do not. 2 of the 25 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).